Search

Prime Medic Group Fined for Unlawful Weight Loss Medicine Advertising

The Therapeutic Goods Administration (TGA) has issued infringement notices totaling $23,760 to Prime Medic Group and an individual for allegedly unlawfully advertising prescription-only weight loss medicines. Prime Medic Group paid the fines in January 2026.

TGA Issues Infringement Notices for Unlawful Importation and Advertising

The Therapeutic Goods Administration (TGA) has issued 11 infringement notices totaling $43,560 to 6 individuals for alleged unlawful importation of unapproved therapeutic goods and unlawful advertising of prescription-only medicines. These actions underscore the TGA's commitment to protecting public health.

TGA Releases Compliance Principles for 2026-2027 Enforcement

The Therapeutic Goods Administration (TGA) has released its compliance principles for 2026-2027, outlining a refreshed, proactive, and risk-based approach to enforcement for therapeutic goods in Australia. The principles apply across all TGA-regulated areas and will be reviewed every two years.

TGA Seizes 57,000 Illegal Vaping Goods in NSW Crackdown

The Therapeutic Goods Administration (TGA) in Australia, with law enforcement support, seized over 57,000 illegal vaping products in Burwood, NSW. This action targets the illicit supply of vapes, with significant penalties including fines and imprisonment for non-compliance with the Therapeutic Goods Act 1989.

Safety Concerns Over Imported Counterfeit Melatonin Products

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding imported counterfeit unregistered melatonin products. Laboratory testing revealed significant discrepancies in melatonin content, with some products containing over 400% of the labelled amount and others none at all, posing serious risks to consumers, especially children.

TGA Safety Advisory: Counterfeit GLP-1 Weight Loss Products

The Therapeutic Goods Administration (TGA) has issued an updated safety advisory regarding counterfeit weight loss products falsely claiming to contain GLP-1 receptor agonists. Laboratory testing confirmed these products contain no active GLP-1 ingredients and are not included in the Australian Register of Therapeutic Goods.

TGA Safety Alert: Counterfeit Botox Vials Continue to be Imported

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding the continued importation of counterfeit Botox vials into Australia. These products, packaged to appear genuine but confirmed as fake by AbbVie, pose significant public health risks and cannot be legally imported under any circumstances.